| Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy (NCT00746018) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Bevacizumab and Carboplatin for Patients With Ovarian Cancer (NCT00744718) | Vejle Hospital | 2008-08-01 |
| The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies (NCT00726635) | Rabin Medical Center | 2008-08-01 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068) | OHSU Knight Cancer Institute | 2008-08-01 |
| Lynne Cohen Consortium Project: Multi-Center Database/Registry (NCT00776958) | M.D. Anderson Cancer Center | 2008-07-01 |
| Genomic Directed Salvage Chemotherapy With Either Liposomal Doxorubicin Or Topotecan (NCT00720096) | H. Lee Moffitt Cancer Center and Research Institute | 2008-07-01 |
| FR in Stored Plasma (NCT00787514) | Royal Marsden NHS Foundation Trust | 2008-07-01 |
| Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors (NCT00722228) | Hadassah Medical Organization | 2008-07-01 |
| Effects of a Teaching Intervention With an Advanced Practice Nurse on Quality of Life and Psychosocial and Symptom Distress in Patients With Ovarian Cancer (NCT00900679) | City of Hope Medical Center | 2008-07-01 |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy (NCT00716976) | Children's Oncology Group | 2008-06-23 |
| Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer (NCT00905658) | Centre Oscar Lambret | 2008-06-01 |
| Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer (NCT00604994) | Queensland Centre for Gynaecological Cancer | 2008-06-01 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families (NCT00782145) | Tufts Medical Center | 2008-06-01 |
| AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer (NCT01445418) | National Cancer Institute (NCI) | 2008-05-12 |
| Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer (NCT00877253) | Samyang Biopharmaceuticals Corporation | 2008-05-01 |
| Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer (NCT00886717) | Asan Medical Center | 2008-05-01 |
| Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer (NCT00562185) | University of Texas Southwestern Medical Center | 2008-05-01 |
| Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod (NCT00799110) | Beth Israel Deaconess Medical Center | 2008-05-01 |
| Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00617773) | Recepta Biopharma | 2008-05-01 |
| A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer (NCT00831636) | Clavis Pharma | 2008-04-01 |
| AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer (NCT00610714) | AstraZeneca | 2008-04-01 |
| Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer (NCT01538498) | National Cancer Center, Korea | 2008-04-01 |
| Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk (NCT00735150) | Memorial Sloan Kettering Cancer Center | 2008-03-01 |
| Tranexamic Acid in Surgery of Advanced Ovarian Cancer (NCT00740116) | Preben Kjolhede, MD, professor | 2008-03-01 |
| Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer (NCT00652899) | Masonic Cancer Center, University of Minnesota | 2008-03-01 |
| Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (NCT00569673) | Gynecologic Oncology Group | 2008-03-01 |
| A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. (NCT00637390) | University of Michigan Rogel Cancer Center | 2008-03-01 |
| Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00634894) | M.D. Anderson Cancer Center | 2008-03-01 |
| Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin (NCT00652119) | Massachusetts General Hospital | 2008-02-01 |
| Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom (NCT00757263) | Cancer Research UK | 2008-02-01 |
| Bone Health in Gynecologic Cancers-does FOSAVANCE Help? (NCT00593580) | British Columbia Cancer Agency | 2008-02-01 |
| A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer (NCT00607607) | CASI pharmaceuticals, Inc. | 2008-01-01 |
| Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas (NCT00750386) | Hellenic Oncology Research Group | 2008-01-01 |
| Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer (NCT00846612) | NYU Langone Health | 2008-01-01 |
| Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors (NCT00569257) | AEterna Zentaris | 2007-12-01 |
| Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer (NCT00664781) | Cancer Research UK | 2007-12-01 |
| Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients (NCT00583622) | M.D. Anderson Cancer Center | 2007-12-01 |
| AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00574951) | Gynecologic Oncology Group | 2007-12-01 |
| A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer (NCT00683241) | Abramson Cancer Center at Penn Medicine | 2007-11-01 |
| Korean Hereditary Breast Cancer Study (NCT00595348) | Korean Breast Cancer Study Group | 2007-11-01 |
| Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction (NCT00757952) | Pine Street Foundation | 2007-11-01 |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer (NCT00898781) | Mayo Clinic | 2007-11-01 |
| Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer (NCT00563836) | Neovii Biotech | 2007-11-01 |
| Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) (NCT00562640) | Memorial Sloan Kettering Cancer Center | 2007-10-16 |
| Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer (NCT00523380) | Novo Nordisk A/S | 2007-10-04 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer (NCT00553683) | Rutgers, The State University of New Jersey | 2007-10-01 |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain (NCT00550654) | National Institutes of Health Clinical Center (CC) | 2007-10-01 |
| Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00838656) | Warwick Medical School | 2007-10-01 |
| Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer (NCT00526799) | Daniela Matei, MD | 2007-09-01 |
| Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma (NCT00531284) | Amgen | 2007-09-01 |
| Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer (NCT00702299) | University of Arizona | 2007-09-01 |
| Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System (NCT00837993) | M.D. Anderson Cancer Center | 2007-08-01 |
| Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes (NCT00496106) | University of California, Irvine | 2007-08-01 |
| Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors (NCT00520013) | Dana-Farber Cancer Institute | 2007-08-01 |
| A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients (NCT00526617) | AbbVie | 2007-08-01 |
| A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer (NCT00516841) | Facet Biotech | 2007-08-01 |
| Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian Cancer (NCT00804258) | City of Hope Medical Center | 2007-08-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor (NCT00523809) | M.D. Anderson Cancer Center | 2007-08-01 |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers (NCT00684801) | Case Comprehensive Cancer Center | 2007-08-01 |
| PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer (NCT00672295) | AA Secord | 2007-08-01 |
| Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer (NCT00477282) | BioNumerik Pharmaceuticals, Inc. | 2007-08-01 |
| Hydralazine Valproate for Ovarian Cancer (NCT00533299) | National Institute of Cancerología | 2007-08-01 |
| HIPEC in Ovarian Cancer, Case-Controls Study With 10-years Follow up (NCT04234243) | Instituto de Seguridad Social del Estado de Mexico y Municipios | 2007-08-01 |
| Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) (NCT00507741) | Endocyte | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer (NCT00479817) | Amgen | 2007-07-05 |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors (NCT00526149) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-07-01 |
| An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer (NCT00532194) | Medical Research Council | 2007-07-01 |
| Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00748527) | Cancer Research UK | 2007-07-01 |
| Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer (NCT00477386) | Indiana University | 2007-07-01 |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission (NCT00522301) | Memorial Sloan Kettering Cancer Center | 2007-07-01 |
| A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) (NCT00539968) | Merck Sharp & Dohme LLC | 2007-06-01 |
| Ovarian Cancer Patient Questionnaire on Genetic Testing (NCT00486707) | M.D. Anderson Cancer Center | 2007-06-01 |
| A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer (NCT00772798) | Herlev Hospital | 2007-06-01 |
| Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer (NCT00617188) | Masonic Cancer Center, University of Minnesota | 2007-06-01 |
| Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer Patients (NCT00562003) | University of Alabama at Birmingham | 2007-06-01 |
| Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers (NCT00545792) | Dana-Farber Cancer Institute | 2007-05-01 |
| Advanced Ovarian Cancer and Sexuality Phase 1 (NCT00488202) | University of British Columbia | 2007-05-01 |
| Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00459290) | Gynecologic Oncology Group | 2007-05-01 |
| Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00536523) | University of Minnesota | 2007-04-01 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors (NCT00465725) | Poniard Pharmaceuticals | 2007-04-01 |
| Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin (NCT00840450) | NYU Langone Health | 2007-04-01 |
| Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas (NCT00474994) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| MRI in Staging Ovarian Cancer Using MRI Contrast Agent (NCT00463996) | University of Aarhus | 2007-04-01 |
| A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma (NCT00434642) | Genentech, Inc. | 2007-04-01 |
| Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin (NCT00436644) | Mayo Clinic | 2007-03-01 |
| Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors (NCT00470366) | Memorial Sloan Kettering Cancer Center | 2007-03-01 |
| Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00667641) | University of Medicine and Dentistry of New Jersey | 2007-03-01 |
| Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment (NCT00453310) | Memorial Sloan Kettering Cancer Center | 2007-03-01 |
| Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA) (NCT00945139) | New Mexico Cancer Research Alliance | 2007-03-01 |
| Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma (NCT00504257) | H. Lee Moffitt Cancer Center and Research Institute | 2007-03-01 |
| Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse (NCT00437307) | North Eastern German Society of Gynaecological Oncology | 2007-03-01 |
| Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer (NCT00426257) | The Netherlands Cancer Institute | 2007-02-01 |
| A Study of Chemotherapy Treatment for Patients With Ovarian Cancer (NCT00428610) | Eli Lilly and Company | 2007-02-01 |
| Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas (NCT00419627) | Hillel Yaffe Medical Center | 2007-02-01 |
| Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer (NCT00431054) | M.D. Anderson Cancer Center | 2007-02-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary (NCT00626873) | Icahn School of Medicine at Mount Sinai | 2007-01-01 |